Cardiovascular Opportunities

Although much of the attention in our Cardiovascular group has centered around the launch of the TAXUS™ product, our R&D teams have been hard at work developing other innovative technologies that we believe will further strengthen our leadership position in coronary and peripheral interventions.

Our Cardiovascular business will continue to grow by expanding the technologies that exist in balloon catheters, Intravascular Ultrasound, guide catheters, guidewires, grafts, stents, and diagnostic devices. These franchises will benefit from new entrants that include the following: